- Home
- / Nipro Corporation
- / Revenue
Nipro CorporationHeader placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Nipro Corporation revenue increased from ¥426.4 billion in 2019 to ¥442.5 billion in 2020, a (3.8%) increase.
Annual Revenue (¥)
Nipro Corporation revenue was ¥442.52 b in FY, 2020 which is a (3.8%) year over year increase from the previous period.
Quarterly Revenue (¥)
Annual Growth Rate (%)
Revenue Breakdown
Business Segment
Geographic Segment
Nipro Corporation revenue breakdown by business segment: 8.2% from PharmaPackaging, 75.9% from Medical-Related, 15.9% from Pharmaceutical-Related and 0.0% from Other
Nipro Corporation revenue breakdown by geographic segment: 11.5% from Europe, 13.5% from Asia, 14.5% from Americas and 60.5% from Japan
| FY, 2020 | FY, 2018 | FY, 2019 | |
|---|---|---|---|
| Other | 174 m | 31 m | 31 m |
| PharmaPackaging | 36.22 b | 28.4 b | 35.53 b |
| Medical-Related | 335.77 b | 300.12 b | 327.36 b |
| Pharmaceutical-Related | 70.36 b | 66.85 b | 63.48 b |
| FY, 2020 | FY, 2018 | FY, 2019 | |
|---|---|---|---|
| Europe | 50.8 b | 46.39 b | 51.04 b |
| Asia | 59.85 b | 50.55 b | 54.55 b |
| Americas | 64.15 b | 56.7 b | 59.84 b |
| Japan | 267.71 b | 241.75 b | 260.97 b |
Need Data?
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.